Piyush Durani

Summary

Publications

  1. doi request reprint Current scales for assessing human scarring: a review
    Piyush Durani
    Division of Regenerative Medicine, Faculty of Medical and Human Sciences, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK
    J Plast Reconstr Aesthet Surg 62:713-20. 2009
  2. doi request reprint The Patient Scar Assessment Questionnaire: a reliable and valid patient-reported outcomes measure for linear scars
    Piyush Durani
    Department of Plastic Surgery Research, Division of Regenerative Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom
    Plast Reconstr Surg 123:1481-9. 2009
  3. doi request reprint Junior doctors and patient safety: evaluating knowledge, attitudes and perception of safety climate
    Piyush Durani
    Department of Plastic and Reconstructive Surgery, University Hospitals Leicester NHS Trust, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, UK
    BMJ Qual Saf 22:65-71. 2013
  4. doi request reprint Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, phase II clinical trial
    James Bush
    Department of Plastic and Reconstructive Surgery, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK
    Plast Reconstr Surg 126:1604-15. 2010
  5. doi request reprint Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trial
    Karen So
    Renovo, Core Technology Facility, Manchester, Leicester, United Kingdom
    Plast Reconstr Surg 128:163-72. 2011
  6. doi request reprint Avotermin: a novel antiscarring agent
    Piyush Durani
    Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom
    Int J Low Extrem Wounds 7:160-8. 2008
  7. doi request reprint Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies
    Mark W J Ferguson
    Faculty of Life Sciences, University of Manchester, Manchester, UK
    Lancet 373:1264-74. 2009

Collaborators

Detail Information

Publications7

  1. doi request reprint Current scales for assessing human scarring: a review
    Piyush Durani
    Division of Regenerative Medicine, Faculty of Medical and Human Sciences, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK
    J Plast Reconstr Aesthet Surg 62:713-20. 2009
    ..The principles of psychometric theory are discussed as a means of developing reliable and valid outcome measures and these are also applicable for measuring outcomes in other fields of plastic surgery research...
  2. doi request reprint The Patient Scar Assessment Questionnaire: a reliable and valid patient-reported outcomes measure for linear scars
    Piyush Durani
    Department of Plastic Surgery Research, Division of Regenerative Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom
    Plast Reconstr Surg 123:1481-9. 2009
    ..There is a lack of rigorously validated patient-based outcomes measures of scarring. The aim of this study was to construct such a scale and demonstrate reliability and validity by applying the scale in a wide range of scarring samples...
  3. doi request reprint Junior doctors and patient safety: evaluating knowledge, attitudes and perception of safety climate
    Piyush Durani
    Department of Plastic and Reconstructive Surgery, University Hospitals Leicester NHS Trust, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, UK
    BMJ Qual Saf 22:65-71. 2013
    ..Engagement of junior doctors in patient safety initiatives is high on the national agenda, but there is a lack of studies evaluating patient safety attitudes among junior doctors...
  4. doi request reprint Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, phase II clinical trial
    James Bush
    Department of Plastic and Reconstructive Surgery, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK
    Plast Reconstr Surg 126:1604-15. 2010
    ..The authors report on a prospective, randomized, placebo-controlled phase II trial to investigate avotermin (transforming growth factor beta-3) for reducing scarring resulting from acute incised skin wounds...
  5. doi request reprint Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trial
    Karen So
    Renovo, Core Technology Facility, Manchester, Leicester, United Kingdom
    Plast Reconstr Surg 128:163-72. 2011
    ..TGF-β3 improves scar appearance in a range of mammalian species. This study was performed to assess the efficacy of intradermal avotermin (TGF-β3) for the improvement of scar appearance following scar revision surgery...
  6. doi request reprint Avotermin: a novel antiscarring agent
    Piyush Durani
    Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom
    Int J Low Extrem Wounds 7:160-8. 2008
    ....
  7. doi request reprint Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies
    Mark W J Ferguson
    Faculty of Life Sciences, University of Manchester, Manchester, UK
    Lancet 373:1264-74. 2009
    ..Research into mechanisms of skin scarring identified transforming growth factor beta3 (TGFbeta3) as a potential antiscarring therapy. We assessed scar improvement with avotermin (recombinant, active, human TGFbeta3)...